BCEIE › News › NEPHROPLUS

Results

Nephrocare Health Services: The financial results for the period ended September 30, 2026

Nephrocare Health Services (NEPHROPLUS) filed a disclosure titled "The financial results for the period ended September 30, 2026". The company is valued at about ₹6,267 crore.

BCEIE News Desk · Published 3 Nov 2026, 06:15 pm IST · Filing received 3 Nov 2026, 06:00 pm IST

What happened

Nephrocare Health Services (NEPHROPLUS) filed a disclosure with the exchanges on 3 November 2026 at 06:00 PM titled "The financial results for the period ended September 30, 2026".

Company snapshot

Nephrocare Health Services is a small-cap company in the Healthcare sector, with a market value of about ₹6,267 crore.

The stock last traded at ₹624.6, against a 52-week range of ₹446–₹781.5 (20.1% below the high).

Before this filing the shares had moved −5.4% over the month and −9.4% over three months. Average daily turnover over the last 20 sessions was about ₹9.57 crore.

Promoters held 63.85% at the end of Q1 FY27. Foreign institutions owned 8.78% and domestic institutions 9.05%.

Quarterly results (consolidated, ₹ crore)
QuarterRevenueNet profitEPS (₹)
Q3 FY2626032.23.43
Q4 FY2626630.43.03
Q1 FY27282323.19

What history shows

BCEIE's records show 2 previous results filings from the company since May 2026.

After those filings, the stock fell 5.1% on average the next trading day and was down 3.0% on average after five days (2 filings with price data).

Across 300 similar disclosures by other Healthcare companies, shares moved +1.4% on average the next day and +1.9% over five days; 57% of them rose the next day.

Market-wide, 10,321 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.

Past reactions describe what happened before; they are not a forecast.

Earlier filings of this kind
DateFilingNext day5 days
11 Aug 2026Results−5.1%−3.0%
11 Aug 2026Financial Results For The Quarter Ended June 30, 2026−5.1%−3.0%

What to watch

  • Management commentary, margins and order book or guidance in the investor presentation.
  • 3 November 2026: Board meeting — Financial Results.

In the news

Recent coverage elsewhere (links open the original publisher):

Source

Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.

More on Nephrocare Health Services Limited